98%
921
2 minutes
20
Introduction: Colorectal cancer (CRC) ranks as the second deadliest cancer globally, impacting patients' quality of life. Colonoscopy is the primary screening method for detecting adenomas and polyps, crucial for reducing long-term CRC risk, but it misses about 30% of cases. Efforts to improve detection rates include using AI to enhance colonoscopy. This study assesses the effectiveness and accuracy of a real-time AI-assisted polyp detection system during colonoscopy.
Materials And Methods: The study included 390 patients aged 40 to 75 undergoing colonoscopies for either colorectal cancer screening (risk score ≥ 4) or clinical diagnosis. Participants were randomly assigned to an experimental group using software-assisted diagnosis or a control group with physician diagnosis. The software, a medical image processing tool with B/S and MVC architecture, operates on Windows 10 (64-bit) and supports real-time image handling and lesion identification via HDMI, SDI, AV, and DVI outputs from endoscopy devices. Expert evaluations of retrospective video lesions served as the gold standard. Efficacy was assessed by polyp per colonoscopy (PPC), adenoma per colonoscopy (APC), adenoma detection rate (ADR), and polyp detection rate (PDR), while accuracy was measured using sensitivity and specificity against the gold standard.
Results: In this multicenter, randomized controlled trial, computer-aided detection (CADe) significantly improved polyp detection rates (PDR), achieving 67.18% in the CADe group versus 56.92% in the control group. The CADe group identified more polyps, especially those 5 mm or smaller (61.03% vs. 56.92%). In addition, the CADe group demonstrated higher specificity (98.44%) and sensitivity (95.19%) in the FAS dataset, and improved sensitivity (95.82% vs. 77.53%) in the PPS dataset, with both groups maintaining 100% specificity. These results suggest that the AI-assisted system enhances PDR accuracy.
Conclusion: This real-time computer-aided polyp detection system enhances efficacy by boosting adenoma and polyp detection rates, while also achieving high accuracy with excellent sensitivity and specificity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00464-025-12080-x | DOI Listing |
Gastro Hep Adv
July 2025
Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California.
Background And Aims: Colonoscopy is the gold standard screening modality for colorectal cancer; however, it is operator-dependent and reliant on exam quality. Incorporating artificial intelligence (AI) into colonoscopy may improve adenoma detection and clinical outcomes, but this is a sociotechnical challenge that requires effective human-AI teaming incorporating provider attitudes.
Methods: We conducted a systematic review of studies evaluating attitudes and perspectives of providers toward AI-assisted colonoscopy.
Case Rep Genet
August 2025
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
is the primary high-risk predisposition gene for familial cutaneous melanoma. In the Netherlands, most carriers of pathogenic germline variants in harbor a unique, population-specific founder variant, c.225_243del, commonly referred to as p16-.
View Article and Find Full Text PDFBraz J Otorhinolaryngol
September 2025
Zhejiang University, College of Medicine, Department of Otolaryngology, Hangzhou City, Zhejiang Province, China.
Objectives: Exosomes play a crucial role in intercellular communication and may contribute to the development of various diseases. Nevertheless, their role in Nasal Polyps (NPs) remains poorly understood. Herein, Nasal Polyp Fibroblasts (NPF) were used to release exosomes, and epithelial cells were cocultured with NPF-derived exosomes to analyze Epithelial-Mesenchymal Transition (EMT) in Chronic Rhinosinusitis (CRS).
View Article and Find Full Text PDFLancet Gastroenterol Hepatol
October 2025
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Endoscopy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Background: Guidelines recommend leaving in situ rectosigmoid polyps diagnosed during colonoscopy that are 5 mm or smaller if the endoscopist optically predicts them to be non-neoplastic. However, no randomised controlled trial has been done to examine the efficacy and safety of this strategy.
Methods: This open-label, multicentre, non-inferiority, randomised controlled trial enrolled adults age 18 years or older undergoing colonoscopy for screening, surveillance, or clinical indications across four Italian centres.
Gastrointest Endosc
September 2025
Geisel School of Medicine at Dartmouth, Hanover, NH; Department of Medicine, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; NH Colonoscopy Registry, Lebanon, NH.
Background And Aims: Data comparing the location of polyp yield in patients with positive stool tests can aid screening test selection. We conducted a cross sectional analysis of New Hampshire Colonoscopy Registry data to compare the location, left versus right side of the colon, of neoplasia detected on colonoscopy following a mt-sDNA+ or FIT+ test as compared to a reference group having colonoscopy without a stool test.
Methods: Our outcomes were advanced lesions (adenoma and/or serrated polyp, including cancer), advanced adenomas (AA), or advanced serrated polyps (ASP), stratified by location.